BICYCLE THERAPEUTICS PLC 088786108 6/17/2026 To approve, on advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3468430 0 FOR 3468430 FOR CRESCENT BIOPHARMA INC. G2545C104 6/2/2026 To approve, on a non-binding, advisory basis, the compensation for our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1677852 0 FOR 1677852 FOR CRESCENT BIOPHARMA INC. G2545C104 6/2/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve the compensation for our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1677852 0 FOR 1677852 FOR DAMORA THERAPEUTICS INC 36322Q206 6/17/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 2441000 0 FOR 2441000 FOR DYNE THERAPEUTICS INC 26818M108 6/5/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 4644386 0 FOR 4644386 FOR 2 NEWAMSTERDAM PHARMA COMPANY N62509109 6/2/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 9198900 0 FOR 9198900 FOR 1 2 REPLIMUNE GROUP INC 76029N106 9/3/2025 To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended March 31, 2026 SECTION 14A SAY-ON-PAY VOTES ISSUER 3656753 0 FOR 3656753 FOR